Updated Jul 16, 2026
Fedock Michael J. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Michael J. Fedock is identified as a corporate insider in IQVIA Holdings Inc. filings (SEC CIK 0002103784) dated 2026-01-30. The filing lists his role under Remarks with no insider transactions reported (purchases or sales), and IQVIA is noted as the company resulting from the Quintiles IMS merger, operating in pharmaceutical R&D services and healthcare data analytics.
| Role | See Remarks |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-17 | IQV | IQVIA HOLDINGS INC. | F — Tax withholding / forfeiture | 123 | $166.94 | $21K |
| 2026-02-10 | IQV | IQVIA HOLDINGS INC. | F — Tax withholding / forfeiture | 2.4K | $187.49 | $454K |
| 2026-02-10 | IQV | IQVIA HOLDINGS INC. | A — Grant or award | 6.7K | $0.00 | |
| 2026-02-10 | IQV | IQVIA HOLDINGS INC. | F — Tax withholding / forfeiture | 111 | $187.49 | $21K |
| 2026-01-30 | IQV | IQVIA HOLDINGS INC. | F — Tax withholding / forfeiture | 381 | $239.76 | $91K |
Michael J. Fedock is identified as a corporate insider in IQVIA Holdings Inc. filings (SEC CIK 0002103784) dated 2026-01-30. The filing lists his role under Remarks with no insider transactions reported (purchases or sales), and IQVIA is noted as the company resulting from the Quintiles IMS merger, operating in pharmaceutical R&D services and healthcare data analytics.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Fedock Michael J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.